Skip to main content
BaxterEarnings

Baxter International stock turns on guidance and buybacks

What happened

Baxter International reported earnings of $0.56 per share for its most recent quarter, exceeding expectations of $0.37.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Baxter International Inc. (US0673431090) is trading against a $2.96 billion second quarter and FY 2026 EPS guidance of $1.95 to $2.15, with the company valued at $13.63 billion in the latest market snapshot. The most recent report showed revenue up 5.3% year over year, while earnings came in at $0.56 a share versus $0.37 expected. That mix matters because it ties the share reaction to both execution and a guidance range that still leaves room for debate. Analyst views also point to a firmer setup than earlier in the summer. One recent summary put the consensus price target at $22.45, while another narrative valued the shares at $28.73 versus a last close of $26.34. The comparison is concrete: the latest quarter's $0.56 EPS exceeded consensus by $0.19, and revenue topped estimates by $160 million. For investors, that gap is the cleanest proof point in the current Baxter story. The same market note said Baxter carried a debt-to-equity ratio of 1.39, a quick ratio of 1.32, and a current ratio of 1.95. Those figures frame the stock around cash discipline as much as around growth. Institutional activity has also stayed active, with one filing showing a new 43,244-share position valued at $922,000 and broader ownership at 90.19% of the float. That kind of ownership mix often keeps attention on operating delivery. Baxter's renal care lineup includes hemodialysis and peritoneal...

Keep reading with a free account

The rest of this article, and every signal for Baxter, is in your free account.

Extracted by Autobound

From the Signal API record
Event
Earnings

What this signalsEarnings results often set the next budget cycle.

The full record

From the Signal API record

Extraction

Confidence
90%
Detected
Aug 22, 2026
signal_type
news
signal_subtype
has_earnings

Use this data

Get every earnings signal for Baxter and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Baxter this week?”

  2. Send it to your own tools

    The Signal API returns earnings signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/34f7f06b-96be-790f-11cd-2b34b6cf0484 returns this record as JSON. POST /v1/companies/enrich returns every signal for baxter.com.

{
  "signal_id": "34f7f06b-96be-790f-11cd-2b34b6cf0484",
  "signal_type": "news",
  "signal_subtype": "has_earnings",
  "detected_at": "2026-08-22T13:21:10+00:00",
  "company": {
    "name": "Baxter",
    "domain": "baxter.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/corporate-news/baxter-international-stock-turns-on-guidance-and-buybacks/69986499",
    "title": "Baxter International stock turns on guidance and buybacks - Ad-hoc-news.de",
    "excerpt": "Baxter International Inc. (US0673431090) is trading against a $2.96 billion second quarter and FY 2026 EPS guidance of $1.95 to $2.15, with the company valued at $13.63 billion in the latest market snapshot. The most recent report showed revenue up 5.3% year over year, while earnings came in at $0.56 a share versus $0.37 expected. That mix matters because it ties the share reaction to both execution and a guidance range that still leaves room for debate. Analyst views also point to a firmer setup than earlier in the summer. One recent summary put the consensus price target at $22.45, while another narrative valued the shares at $28.73 versus a last close of $26.34. The comparison is concrete: the latest quarter's $0.56 EPS exceeded consensus by $0.19, and revenue topped estimates by $160 million. For investors, that gap is the cleanest proof point in the current Baxter story. The same market note said Baxter carried a debt-to-equity ratio of 1.39, a quick ratio of 1.32, and a current ratio of 1.95. Those figures frame the stock around cash discipline as much as around growth. Institutional activity has also stayed active, with one filing showing a new 43,244-share position valued at $922,000 and broader ownership at 90.19% of the float. That kind of ownership mix often keeps attention on operating delivery. Baxter's renal care lineup includes hemodialysis and peritoneal...",
    "summary": "Baxter International reported earnings of $0.56 per share for its most recent quarter, exceeding expectations of $0.37.",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2699598_1920_1080.webp",
    "confidence": 0.9,
    "published_at": "2026-08-22T13:21:10Z",
    "article_sentence": "The most recent report showed revenue up 5.3% year over year, while earnings came in at $0.56 a share versus $0.37 expected."
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.